Bayer and Atara Biotherapeutics Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors

Go back to Bayer and Atara Biotherapeutics Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors
(NASDAQ: ATRA) Delayed: 9.76 +0.23 (2.41%)
Previous Close $9.53    52 Week High $40.80 
Open $9.45    52 Week Low $12.45 
Day High $9.95    P/E N/A 
Day Low $9.25    EPS $0.00 
Volume 135,657